Singapore markets open in 3 hours 40 minutes

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
44.37+1.05 (+2.42%)
At close: 04:00PM EDT
44.33 -0.04 (-0.09%)
After hours: 05:15PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close43.32
Bid44.19 x 800
Ask44.38 x 4000
Day's range43.76 - 44.49
52-week range37.80 - 46.97
Avg. volume5,142,436
Market cap112.788B
Beta (5Y monthly)0.37
PE ratio (TTM)18.02
EPS (TTM)2.46
Earnings date01 Feb 2017 - 06 Feb 2017
Forward dividend & yield1.99 (4.59%)
Ex-dividend date19 May 2022
1y target est49.81
  • Motley Fool

    Was This Acquisition a Smart Move for GlaxoSmithKline?

    The British drugmaker recently announced that it agreed to acquire a late-stage biopharmaceutical company.

  • Motley Fool

    Why GSK May Have Bet Too Big on a Pandemic Pipeline

    Pharmaceutical giant GlaxoSmithKline (NYSE: GSK) missed out on this early action and now looks to launch several pandemic products this year. GSK has three separate COVID vaccines in late-stage development, in various partnerships with Sanofi (NASDAQ: SNY), South Korean pharmaceutical SK bioscience, and Canadian biopharmaceutical Medicago. GSK's Phase 3 clinical trials are wrapping up, and GSK expects regulatory decisions in the US and EU starting later this year.

  • Zacks

    Gilead (GILD) Q1 Earnings Beat on Solid COVID Treatment Sales

    Gilead (GILD) beats on earnings and revenues in the first quarter on strong Veklury sales. HIV business maintains momentum on Biktarvy.